Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dubsky

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|September 18, 2010
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort studyF Fitzal, O Riedl, M Mittlböck, et al.
Anticancer Research|April 13, 2001
Heat treatment of hepatocellular carcinoma cells: increased levels of heat shock proteins 70 and 90 correlate with cellular necrosisG Schueller, P Paolini, J Friedl, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2004
High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCISS Roka, M Rudas, S Taucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancerS F Schoppmann, D Tamandl, L Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Dendritic cell-based vaccination in solid cancerA Stift, J Friedl, P Dubsky, et al.
British Journal of Cancer|April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trialF Fitzal, M Filipits, M Rudas, et al.
European Radiology|March 19, 2013
Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesionsK Pinker, H Bickel, T H Helbich, et al.
Endocrine-Related Cancer|March 26, 2003
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapyS Taucher, M Rudas, M Gnant, et al.
European Radiology|September 14, 2011
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?K Pinker-Domenig, W Bogner, S Gruber, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cellsT Bachleitner-Hofmann, A Stift, J Friedl, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|September 18, 2010
Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort studyF Fitzal, O Riedl, M Mittlböck, et al.
Anticancer Research|April 13, 2001
Heat treatment of hepatocellular carcinoma cells: increased levels of heat shock proteins 70 and 90 correlate with cellular necrosisG Schueller, P Paolini, J Friedl, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 19, 2004
High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCISS Roka, M Rudas, S Taucher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2009
HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancerS F Schoppmann, D Tamandl, L Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Dendritic cell-based vaccination in solid cancerA Stift, J Friedl, P Dubsky, et al.
British Journal of Cancer|April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trialF Fitzal, M Filipits, M Rudas, et al.
European Radiology|March 19, 2013
Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesionsK Pinker, H Bickel, T H Helbich, et al.
Endocrine-Related Cancer|March 26, 2003
Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapyS Taucher, M Rudas, M Gnant, et al.
European Radiology|September 14, 2011
High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?K Pinker-Domenig, W Bogner, S Gruber, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cellsT Bachleitner-Hofmann, A Stift, J Friedl, et al.
Pageof 5